RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RADX RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD

交易中 08-07 09:58:47 EDT

2.77

-0.02

-0.72%

最高2.90	最低2.75	成交量1.46万
今开2.90	昨收2.79	日振幅5.37%
总市值4,005万	流通市值2,336万	总股本1,446万
成交额4.05万	换手率0.17%	流通股本843.42万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RADX","market":"US","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD","latestPrice":2.77,"timestamp":1786111060344,"preClose":2.79,"halted":0,"volume":14579,"delay":0,"changeRate":-0.007168458781362013,"floatShares":8434200,"shares":14458500,"eps":-3.808831,"marketStatus":"交易中","change":-0.02,"latestTime":"08-07 09:58:47 EDT","open":2.9,"high":2.9,"low":2.7501,"amount":40486.378686000004,"amplitude":0.053728,"askPrice":2.91,"askSize":19,"bidPrice":2.75,"bidSize":112,"shortable":3,"etf":0,"ttmEps":-3.808831,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786132800000},"marketStatusCode":2,"adr":0,"adrRate":300,"exchange":"NASDAQ","adjPreClose":2.79,"preHourTrading":{"tag":"盘前","latestPrice":2.89,"preClose":2.79,"latestTime":"09:20 EDT","volume":3275,"amount":9038.614205,"timestamp":1786108857274,"change":0.1,"changeRate":0.035842,"amplitude":0.064516},"postHourTrading":{"tag":"盘后","latestPrice":2.7499,"preClose":2.79,"latestTime":"19:42 EDT","volume":3099,"amount":8070.8386,"timestamp":1786059770434,"change":-0.0401,"changeRate":-0.014373,"amplitude":0.157706},"volumeRatio":2.647403},"requestUrl":"/m/hq/s/RADX/tweets","defaultTab":"tweets","newsList":[{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STX","TTWO","TRMB","GEHC","ADBE","USAW.SI","CG","AUR","NTNX","NXPI","TW","MKSI","OLED","NQmain","ROIV","EA","MRVL","WTFC","AKAM","MNQmain","BIIB","SWKS","ROST","EQIX","ILMN","DUOL","TPG","EWBC","RKLB","SSNC","PAA","TSCO","TROW","COKE","NWSA","ZS","CSWI","LI","USJW.SI","RADX","WYNN","AEP","BPOP","MDB","RGEN","CCEP","DDOG","AMD","PNFP","HLNE","DOX","JD","QQQ","NVDA","BK4581","MANH","CHTR","AAL","NDSN","Z","CTAS","CYBR","GNTX","AMGN","DOCU","LULU","ORLY","PCTY","ISRG","SFM","SBAC","CINF","MARA","TQQQ","ICLR","MNST","ADI","CASY","PLTR","LIN","LKQ","AFRM","FFIV","CPB","GLPI","SMCI","BK4585","RYAAY","MCHP","MELI","CFLT","LU1815336091.USD","SAIA","TMUS","ODFL","AMZN","AAON","ASML","AZN","QCOM","FTNT","HTHT","LU2065731478.USD","COO","AXON","DLTR","INTU","META","KDP","MNDY","RGLD","EVRG","GTLB","FER","WBA","FSLR","LNT","CWST","LSTR","ON","KHC","LNW","WDC","HOOD","REG","NDAQ","HOLX","SNPS","FRPT","CDW","APA","AGNC","CHKP","MSFT","ALGN","BMRN","QID","FAST","FWONK","RVMD","TSEM","JKHY","PODD","SQQQ","TTD","DASH","LOGI","LU0053671581.USD","ZM","ENPH","SIRI","EXAS","MEDP","NTRA","TSLA","BKNG","CRWD","EXE","HST","NTAP","NTRS",".IXIC","ONC","CHDN","DKNG","GILD","GEN","ULTA","RIVN","QLD","CZR","NVMI","AAPL","IDXX","FCNCA","MMYT","LPLA","PCAR","TER","ERIC","CBSH","ADSK","LSCC","CHRD","NICE","ALNY","BK4550","ESLT","MTCH","NBIX","LU0757428866.USD","CTSH","CHRW","GRAB","FOX","HQY","QRVO","CPRT","LAMR","HSIC","TSYW.SI","WWD","HBAN","MTSI","BKR","MDLZ","MKTX","PAYX","ERIE","PTC","GOOGL","PCVX","PEP","BK4534","ROKU","SRPT","AMAT","NVIW.SI","ITCI","ARGX","CME","AVGO","INTC","FYBR","BK4086","MIDD","SBUX","FOXA","NTES","QXO","ROP","PFG","MPWR","REGN","SEIC","EBAY","GMAB","ARM","EXPE","TLN","CSGP","BK4561","COIN","OKTA","COST","DPZ","BK4588","HON","JBHT","NFLX","CSX","BK4593","LECO","STLD","PARA","ENTG","MRNA","SOFI","INCY","TXN","OTEX","RPRX","PSQ","DSGX","TECH","PDD","POOL","TTEK","BSY","TEAM","CDNS","ANSS","TCOM","BPMC","CEG","FTAI","BRKR","ALAB","CSCO","INSM","FSV"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.radiopharmtheranostics.com","stockEarnings":[{"period":"1week","weight":-0.1281},{"period":"1month","weight":-0.342},{"period":"3month","weight":-0.3025},{"period":"6month","weight":-0.4386},{"period":"1year","weight":-0.4474},{"period":"ytd","weight":-0.4655}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Radiopharm Theranostics Limited于2021年2月根据澳大利亚法律注册成立。该公司是一家研发公司，旨在开发和商业化用于精准肿瘤学治疗和诊断应用的放射性药物产品平台。他们开发的靶向和经过科学验证的放射性药物技术处于临床前和临床开发阶段。这些技术涵盖所有大小的分子，包括多肽、小分子和附着在医疗质量放射性同位素上的抗体。他们正在美国、欧盟、英国、中国、日本、澳大利亚和加拿大寻求每一种在研产品和疗法的注册和上市批准。","exchange":"NASDAQ","name":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD","nameEN":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD,RADX,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票老虎,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票老虎国际,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD行情,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票行情,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股价,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股市,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票价格,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票交易,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票购买,RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}